A meta-analysis of comparing EGFR-TKI with chemotherapy as the second-line treatment of NSCLC patients with wild-type EGFR.

作者:Gao, Guanghui; Ren, Shengxiang; Li, Aiwu; He, Yayi; Chen, Xiaoxia; Li, Wei; Zhou, Fei; Li, Shuai; Zhou, Caicun
来源:Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, IL, 2013-05-31 To 2013-06-04.
  • 出版日期2013-5-20
  • 单位同济大学; 同济大学附属上海市肺科医院